CC BY-NC-ND 4.0 · Indian Journal of Cardiovascular Disease in Women - WINCARS 2020; 5(03): 227-229
DOI: 10.1055/s-0040-1718866
Review Article

Management of COVID-19

Mary John
1  Department of Medicine, Christian Medical College and Hospital, Ludhiana, Punjab, India
› Author Affiliations

Abstract

The SARS-CoV-2 (COVID-19) pneumonia was first seen in Wuhan province, China, in December 2019. Since then, there has been great efforts toward understanding the pathophysiology and management of this disease, which was declared as a pandemic in March 2020. Medications which were initially used have been removed and newer ones are under clinical evaluation. Oxygen therapy, anti-inflammatory and antiviral medication, along with awake proning are currently being used in the management of COVID-19.



Publication History

Publication Date:
12 October 2020 (online)

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Siddiqui HK, Mehra M. COVID-19 illness in native and immunosupressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant 2020 (e-pub ahead of print). doi: https://dx.doi.org/10.1016%2Fj.healun.2020.03.01
  • 2 Government of India, Ministry of Health and Family Welfare, Directorate General of Health Services (EMR Division); Version 5; dated 03.07.20. Available at: https://www.mohfw.gov.in/. Accessed July 10, 2020
  • 3 Gupta A, Madhavan MV, Sehgal K. et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020; 26 (07) 1017-1032
  • 4 Infectious Disease Society of America Guidelines on the treatment and Management of Patients with COVID-19 (updated18/6/2020). Available at: https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/. Accessed July 10, 2020